NeoGenomics provides cancer diagnostic testing and pathology interpretation services for doctors, hospitals and drug developers. It last closed at $14.82 on Nov 20, down 1.79% on the day. The next earnings report for NEO is expected around Tue, Jan 26, 2027. Over its last 8 reports the stock moved an average of 11.1% the session after earnings. Over the last 12 months NEO insiders bought $0 of stock on the open market and sold $968K, according to SEC Form 4 filings.
AI Auto Pilots
Is NEO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NEO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on NEOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
NEO · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 12% below its 20 day and 17% below its 50 day average. It is 12% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot S1 at $14.59, and the nearest resistance the Pivot at $14.86.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 5.5%/day
Key levels
$20.1552 week high+36.0%
$17.3250 day average+16.9%
$16.59100 day average+11.9%
$16.5420 day average+11.6%
$15.10Pivot R1+1.9%
$15.04Swing high (Jul 17)+1.5%
$14.86Pivot+0.3%
$14.82Last close
$14.59Pivot S1−1.6%
$13.81Swing low (Jul 8)−6.8%
$13.07200 day average−11.8%
$7.0752 week low−52.3%
Indicators
RSI (14)
34.25
Weak, oversold below 30
Neutral
MACD
-0.55
Below its signal line
Bearish
Stochastic
9.2
Near the bottom of its range
Oversold
ADX (14)
19.6
No clear trend
Williams %R
-93.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-154.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−12.0%
Change over 10 sessions
Bearish
ATR (14)
$0.81
Typical daily range, 5.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 12.0%/day
Key levels
$20.1552 week high+36.0%
$17.3250 day average+16.9%
$16.59100 day average+11.9%
$16.5420 day average+11.6%
$15.10Pivot R1+1.9%
$15.04Swing high (Jul 17)+1.5%
$14.86Pivot+0.3%
$14.82Last close
$14.59Pivot S1−1.6%
$13.81Swing low (Jul 8)−6.8%
$13.07200 day average−11.8%
$7.0752 week low−52.3%
Indicators
RSI (14)
47.79
Middle of its range
Neutral
MACD
1.06
Below its signal line
Bearish
Stochastic
15.8
Near the bottom of its range
Oversold
ADX (14)
38.0
Trending up
Williams %R
-96.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-91.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.4%
Change over 10 sessions
Bearish
ATR (14)
$1.78
Typical daily range, 12.0% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for NEO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how NEO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow NEO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for NEOHow many large options trades hit NEO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in NEO in the last 90 days.
From SEC Form 4 filings by NEO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NEO is in one of them and how their past NEO trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Neogenomics
NeoGenomics provides cancer diagnostic testing and related consulting services from its headquarters in Fort Myers, Florida. Its laboratories run tests such as cytogenetics, flow cytometry, molecular and sequencing panels, and residual disease testing, and its pathologists and molecular experts interpret the results. Its customers include community pathology and oncology practices, hospitals, reference labs, academic centers and pharmaceutical companies. The company also offers research support and data licensing services to drug developers.